Suppr超能文献

相似文献

1
Cytomegalovirus vaccines.
Clin Infect Dis. 2013 Dec;57 Suppl 4(Suppl 4):S196-9. doi: 10.1093/cid/cit587.
2
A cytomegalovirus DNA vaccine induces antibodies that block viral entry into fibroblasts and epithelial cells.
Vaccine. 2015 Dec 16;33(51):7328-7336. doi: 10.1016/j.vaccine.2015.10.078. Epub 2015 Oct 24.
4
Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection.
Vaccine. 2008 Oct 23;26(45):5760-6. doi: 10.1016/j.vaccine.2008.07.092. Epub 2008 Aug 19.
6
The next generation recombinant human cytomegalovirus vaccine candidates-beyond gB.
Vaccine. 2012 Nov 19;30(49):6980-90. doi: 10.1016/j.vaccine.2012.09.056. Epub 2012 Oct 3.
7
Development of a cytomegalovirus vaccine: lessons from recent clinical trials.
Expert Opin Biol Ther. 2001 May;1(3):401-12. doi: 10.1517/14712598.1.3.401.
10
Vaccine Development for Cytomegalovirus.
Adv Exp Med Biol. 2018;1045:271-296. doi: 10.1007/978-981-10-7230-7_13.

引用本文的文献

1
The Fourth International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation.
Transplantation. 2025 Jul 1;109(7):1066-1110. doi: 10.1097/TP.0000000000005374. Epub 2025 Apr 9.
3
Antiviral Approach to Cytomegalovirus Infection: An Overview of Conventional and Novel Strategies.
Microorganisms. 2023 Sep 22;11(10):2372. doi: 10.3390/microorganisms11102372.
4
Recombinant vaccines in 2022: a perspective from the cell factory.
Microb Cell Fact. 2022 Oct 5;21(1):203. doi: 10.1186/s12934-022-01929-8.
5
Production- and Purification-Relevant Properties of Human and Murine Cytomegalovirus.
Viruses. 2021 Dec 10;13(12):2481. doi: 10.3390/v13122481.
8
Killer cell proteases can target viral immediate-early proteins to control human cytomegalovirus infection in a noncytotoxic manner.
PLoS Pathog. 2020 Apr 13;16(4):e1008426. doi: 10.1371/journal.ppat.1008426. eCollection 2020 Apr.
9
CMV Prevention and Treatment in Transplantation: What's New in 2019.
Curr Infect Dis Rep. 2019 Nov 15;21(11):45. doi: 10.1007/s11908-019-0699-0.
10
Stabilization and formulation of a recombinant Human Cytomegalovirus vector for use as a candidate HIV-1 vaccine.
Vaccine. 2019 Oct 16;37(44):6696-6706. doi: 10.1016/j.vaccine.2019.09.027. Epub 2019 Sep 20.

本文引用的文献

2
Antibody inhibition of human cytomegalovirus spread in epithelial cell cultures.
J Virol Methods. 2013 Sep;192(1-2):44-50. doi: 10.1016/j.jviromet.2013.04.015. Epub 2013 May 10.
5
Neutralizing activity of saliva against cytomegalovirus.
Clin Vaccine Immunol. 2011 Sep;18(9):1536-42. doi: 10.1128/CVI.05128-11. Epub 2011 Jul 27.
9
Vaccine prevention of maternal cytomegalovirus infection.
N Engl J Med. 2009 Mar 19;360(12):1191-9. doi: 10.1056/NEJMoa0804749.
10
Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection.
Vaccine. 2008 Oct 23;26(45):5760-6. doi: 10.1016/j.vaccine.2008.07.092. Epub 2008 Aug 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验